Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. Hurtado
Psy100 - Cost-Effectiveness Analysis of Second Line Treatment for Patients With Ulcerative Colitis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcn178 - Cost-Effectiveness of Pembrolizumab as Second-Line Treatment for Patients With Advanced Urothelial Cancer in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Delaying Second Line Diabetes Treatment Onset in Patients Uncontrolled With Metformin Xr in Saudi Arabia: Cost-Effectiveness Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Infliximab for the Treatment of Acute Exacerbations of Ulcerative Colitis in the Netherlands
Biologics in Therapy
Cost Effectiveness of Regorafenib as Second-Line Therapy for Patients With Advanced Hepatocellular Carcinoma
Cancer
Cancer Research
Oncology
Treatment for Ulcerative Colitis
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line Setting
Journal of Oncology
Oncology
Treatment of Ulcerative Colitis
JAMA - Journal of the American Medical Association
Medicine
Cost-Utility Analysis of Infliximab and Adalimumab for Refractory Ulcerative Colitis
Cost Effectiveness and Resource Allocation
Health Policy
Treatment of Ulcerative Colitis
BMJ
